SL
BMY icon

Savior LLC’s Bristol-Myers Squibb BMY Stock Holding History

Savior LLC’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-419
Closed -$28K – 257
2021
Q2 		$28K Sell
419
-300
-42% -$19.6K 0.02% 229
2021
Q1 		$45K Hold
719
– – 0.05% 163
2020
Q4 		$45K Hold
719
– – 0.04% 161
2020
Q3 		$43K Hold
719
– – 0.05% 146
2020
Q2 		$42K Buy
719
+146
+25% +$8.73K 0.05% 133
2020
Q1 		$32K Sell
573
-36
-6% -$2.2K 0.04% 149
2019
Q4 		$39K Buy
+609
New +$34.9K 0.05% 181

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Savior LLC's BMY Position: Q3 2021 in Review

Savior LLC sold out of Bristol-Myers Squibb (BMY) in Q3 2021, closing a stake of 419 shares — an estimated $28K sold.

Savior LLC first reported a position in BMY in Q4 2019 and held it in 7 quarters. The position peaked at $45K in Q1 2021. 2,292 funds tracked by Wall St. Rank hold BMY as of Q3 2021.

  • Savior LLC reported no remaining Bristol-Myers Squibb position as of Q3 2021 after selling out during the quarter.
  • Savior LLC sold 419 Bristol-Myers Squibb shares in Q3 2021, an estimated $28K.
  • Savior LLC first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 7 quarters.
  • Savior LLC's Bristol-Myers Squibb position peaked at $45K in Q1 2021.
  • 2,292 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.

Based on Savior LLC's 13F filing for Q3 2021, filed 5 Oct 2021.